Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Some patients may experience mild injection site discomfort, dizziness, or nausea
Developed in the late 1990s/early 2000s as a focused hGH fragment, AOD-9604 was advanced into early clinical programs to investigate mechanism-driven metabolic effects and safety
Current FDA concern The FDA says compounded AOD-9604 may carry immunogenicity risks for some routes and may have problems linked to peptide impurities and product characterization
The product, being a liquid solution, is refrigerated, and should be protected from light
Change the location with every B12 injection to minimize inflammation and the risk of tissue damage
:format(webp))
US$ 20.83
US$ 27.25
US$ 26.20
US$ 22.90
